SANGAMO THERAPEUTICS, INC. Accounts Payable
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Accounts Payable of $19.31 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-05-14
- 2026-03-31: Accounts Payable, Current $19.31M.
- 2025-12-31: Accounts Payable, Current $14.44M.
- 2025-09-30: Accounts Payable, Current $15.56M.
- 2025-06-30: Accounts Payable, Current $10.74M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-03-31 | $19.31M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $14.44M 10-Q · filed 2026-05-14 |
| 2025-09-30 | $15.56M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $10.74M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $18.20M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $15.48M 10-K · filed 2026-03-30 |
| 2024-09-30 | $19.79M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $17.59M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $15.47M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $15.26M 10-K · filed 2025-03-17 |
| 2023-09-30 | $15.46M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $14.84M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $19.92M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $22.42M 10-K · filed 2024-03-13 |
| 2022-09-30 | $17.38M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $13.08M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $11.15M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $9.76M 10-K · filed 2023-02-23 |
| 2021-09-30 | $7.98M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $10.13M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $11.64M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $12.55M 10-K · filed 2022-02-24 |
| 2019-12-31 | $6.67M 10-K · filed 2021-02-24 |
| 2018-12-31 | $3.35M 10-K · filed 2020-02-28 |
| 2017-12-31 | $16.00K 10-K · filed 2019-03-01 |
| 2016-12-31 | $2.58M 10-K · filed 2018-03-01 |
| 2015-12-31 | $3.90M 10-K · filed 2017-02-28 |
| 2014-12-31 | $5.53M 10-K · filed 2016-02-18 |
| 2013-12-31 | $3.02M 10-K · filed 2015-02-25 |
| 2012-12-31 | $3.05M 10-K · filed 2014-02-24 |
| 2011-12-31 | $4.11M 10-K · filed 2013-02-26 |